COVID-19 Rebound

CE / CME

COVID-19 Antiviral Agents and COVID-19 Rebound

Pharmacists: 0.75 contact hour (0.075 CEUs)

Nurses: 0.75 Nursing contact hour

Physicians: Maximum of 0.75 AMA PRA Category 1 Credit

Released: November 22, 2022

Expiration: November 21, 2023

Jason Gallagher
Jason Gallagher, PharmD
Emily Heil
Emily Heil, PharmD, MS, BCIDP, AAHIVP

Activity

Progress
1
Course Completed

In this episode, Jason Gallagher, PharmD, and Emily Heil, PharmD, MS, BCIDP discuss landmark clinical trials of COVID-19 antivirals for nonhospitalized patients and COVID-19 rebound phenomenon, including:

  • EPIC-HR study of nirmatrelvir plus ritonavir
  • PINETREE study of remdesivir
  • MOVe-OUT and Panoramic studies of molnupiravir
  • COVID-19 rebound in treated and untreated patients